Hepatic steatosis, fibrosis, and cancer in elderly cadavers

Anatomical Record

Volumn 295, Issue 1, 2012, Pages 40-50

  Mak, Ki M ^a   Kwong, Allison J ^a   Chu, Edward ^a   Hoo, Nancy M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Elderly cadavers; Fibrosis; Lipofuscin; Liver; Steatosis

Indexed keywords

EOSIN; HEMATOXYLIN; LIPOFUSCIN; PARAFFIN;

AGED; ANATOMY; ARTICLE; CADAVER; CAUSE OF DEATH; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FATTY LIVER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METASTASIS; MALE; PORTAL VEIN; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AGING; CADAVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FATTY LIVER; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE;

EID: 83655183183     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21525     Document Type: Article

References (34)

1. Anantharaju A, Feller A, Chedid A. 2002. Aging liver. Gerontology 48: 343-353.
2. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. 2000. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117.
3. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
4. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474.
5. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. 1994. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20: 349-355.
6. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. 2010. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138: 513-521.
7. Frith J, Day CP, Henderson E, Burt AD, Newton JL. 2009. Non-alcoholic fatty liver disease in older people. Gerontology 55: 607-613.
8. Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. 2004. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 35: 196-199.
9. Jansen PL. 2002. Liver disease in the elderly. Best Pract Res Clin Gastroenterol 16: 149-158.
10. Junge J, Horn T, Vyberg M, Christoffersen P, Svendsen LB. 1991. The pattern of fibrosis in the acinar zone 3 areas in early alcoholic liver disease. J Hepatol 12: 83-86.
11. Junqueira LC, Bignolas G, Brentani RR. 1979. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455.
12. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
13. Lawrence SP. 2000. Advances in the treatment of hepatitis C. Adv Intern Med 45: 65-105.
14. Le Couteur DG, Cogger VC, Markus AM, Harvey PJ, Yin ZL, Ansselin AD, McLean AJ. 2001. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 33: 537-543.
15. Lieber CS, Robins SJ, Li J, DeCarli LM, Mak KM, Fasulo JM, Leo MA. 1994. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106: 152-159.
16. Lopez-De Leon A, Rojkind M. 1985. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33: 737-743.
17. Martín-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V. 2009. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. J Viral Hepat 16: 790-795.
18. Martín-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, Arizcorreta A, Gonzalez A, Rockstroh J, Asensi V, Miralles P, Laguno M, Moreno L, Girón JA, Vogel M, García-Samaniego J, Nuñez M, Romero M, Moreno S, de la Cruz JJ, Soriano V. 2004. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 38: 128-133.
19. McLean AJ, Cogger VC, Chong GC, Warren A, Markus AM, Dahlstrom JE, Le Couteur DG. 2003. Age-related pseudocapillarization of the human liver. J Pathol 200: 112-117.
20. Mueller S, Millonig G, Seitz HK. 2009. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 15: 3462-3471.
21. Nakano M, Worner TM, Lieber CS. 1982. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 83: 777-785.
22. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. 2003. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97: 3036-3043.
23. Persico M, Iolascon A. 2010. Steatosis as a co-factor in chronic liver diseases. World J Gastroenterol 16: 1171-1176.
24. Popper H, Lieber CS. 1980. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98: 695-716.
25. Porto LC, Chevallier M, Grimaud JA. 1989. Morphometry of terminal hepatic veins. 1. Comparative study in man and baboon. Virchows Arch A Pathol Anat 414: 129-134.
26. Powell EE, Jonsson JR, Clouston AD. 2005. Steatosis: co-factor in other liver diseases. Hepatology 42: 5-13.
27. Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, Norha P, Munteanu M, Drane F, Messous D, Bismut FI, Carrau JP, Massard J, Ratziu V, Giordanella JP. 2010. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 10: 40.
28. Ramadori G, Saile B. 2004. Portal tract fibrogenesis in the liver. Lab Investig 84: 153-159.
29. Savolainen V, Perola M, Lalu K, Penttilä A, Virtanen I, Karhunen PJ. 1995. Early perivenular fibrogenesis-precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol 23: 524-531.
30. Schmucker DL. 2005. Age-related changes in liver structure and function: implications for disease? Exp Gerontol 40: 650-659.
31. Shirai M, Nagashima K, Iwasaki S, Mori W. 1987. A light and scanning electron microscopic study of hepatic veno-occlusive disease. Acta Pathol Jpn 37: 1961-1971.
32. Tsang SW, Ng WF, Wu BP, Chow DA, Li ET, Wong TC. 2006. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 21: 116-121.
33. Tygstrup N, Sschiodt T, Winkler K. 1965. Correlation between pathological and clinical findings in 195 consecutive liver biopsies showing brown pigments. Gut 6: 194-199.
34. Worner TM, Lieber CS. 1985. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627-630.